Handa Pharmaceuticals, Inc. (TPEX:6620)

Handa Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,013	10,576	25,891	16,074	8,451	2,820
Market Cap Growth	-10.45%	-59.15%	61.07%	90.20%	199.72%	-18.91%
Enterprise Value	10,213	8,085	23,747	15,869	8,249	2,326
Last Close Price	82.20	73.55	178.94	118.56	65.84	23.11
PE Ratio	19.43	22.37	35.62	-	-	-
PS Ratio	9.73	12.73	23.40	81.32	289.08	97.71
PB Ratio	3.08	3.39	9.39	22.29	18.25	5.23
P/TBV Ratio	3.78	4.89	9.52	23.46	19.80	5.59
P/FCF Ratio	54.99	21.59	38.79	-	-	-
P/OCF Ratio	51.59	21.25	38.74	-	-	-
EV/Sales Ratio	7.64	9.73	21.47	80.28	282.15	80.61
EV/EBITDA Ratio	11.91	19.20	34.00	-	-	-
EV/EBIT Ratio	13.29	19.34	34.25	-	-	-
EV/FCF Ratio	43.16	16.51	35.58	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.04	0.03	0.03
Debt / EBITDA Ratio	0.06	0.09	0.02	-	-	-
Debt / FCF Ratio	0.21	0.08	0.02	-	-	-
Asset Turnover	0.34	0.26	0.58	0.31	0.05	0.04
Quick Ratio	9.13	8.49	12.89	11.63	10.05	9.05
Current Ratio	9.17	8.72	12.96	13.07	10.57	10.79
Return on Equity (ROE)	17.42%	16.10%	41.81%	-6.76%	-49.43%	-41.47%
Return on Assets (ROA)	12.36%	8.07%	22.64%	-8.54%	-29.36%	-27.20%
Return on Capital (ROIC)	13.40%	8.82%	24.62%	-8.99%	-30.89%	-28.46%
Return on Capital Employed (ROCE)	18.00%	13.10%	24.50%	-	-	-
Earnings Yield	4.77%	4.47%	2.81%	-0.25%	-2.93%	-10.00%
FCF Yield	1.82%	4.63%	2.58%	-1.32%	-2.19%	-11.20%
Dividend Yield	1.82%	2.04%	0.56%	-	-	-
Payout Ratio	-	29.84%	-	-	-	-
Buyback Yield / Dilution	-4.96%	-4.73%	-7.29%	-6.65%	-1.87%	-5.35%
Total Shareholder Return	-3.13%	-2.69%	-6.73%	-6.65%	-1.87%	-5.35%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.